Literature DB >> 2848241

NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity.

M J Lenardo1, A Kuang, A Gifford, D Baltimore.   

Abstract

The activity of the enhancer for the kappa immunoglobulin light chain gene critically depends on the presence in the nucleus of the NF-kappa B protein. We purified NF-kappa B over 50,000-fold and identified two protein species, 42 and 44 kDa, that could be eluted and renatured from a sodium dodecyl sulfate/polyacrylamide gel to give specific DNA-binding activity. Binding of the purified bovine NF-kappa B as well as that from human and murine B- or T-lymphoid cell extracts was dramatically stimulated by nucleoside triphosphates. This effect distinguished NF-kappa B from a related factor, H2-TF1. Purified NF-kappa B interacted efficiently with regulatory sequences that function during either B- or T-lymphocyte activation, including the human immunodeficiency virus enhancer and a NF-kappa B binding site we detected in the interleukin 2 enhancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848241      PMCID: PMC282599          DOI: 10.1073/pnas.85.23.8825

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 2.  Regulation of genome rearrangement events during lymphocyte differentiation.

Authors:  F W Alt; T K Blackwell; R A DePinho; M G Reth; G D Yancopoulos
Journal:  Immunol Rev       Date:  1986-02       Impact factor: 12.988

3.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro.

Authors:  K A Jones; K R Yamamoto; R Tjian
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

5.  Affinity purification of sequence-specific DNA binding proteins.

Authors:  J T Kadonaga; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

7.  Structure of the human interleukin 2 gene.

Authors:  T Fujita; C Takaoka; H Matsui; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  Organization and structure of the mouse interleukin-2 gene.

Authors:  A Fuse; T Fujita; H Yasumitsu; N Kashima; K Hasegawa; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

10.  Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.

Authors:  F K Wu; J A Garcia; D Harrich; R B Gaynor
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  53 in total

1.  Regulation of c-Rel nuclear localization by binding of Ca2+/calmodulin.

Authors:  Asa Antonsson; Kate Hughes; Sofia Edin; Thomas Grundström
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

2.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells.

Authors:  X Li; W S Liao
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

4.  Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting.

Authors:  F Demarchi; P D'Agaro; A Falaschi; M Giacca
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.

Authors:  C B Thompson; C Y Wang; I C Ho; P R Bohjanen; B Petryniak; C H June; S Miesfeldt; L Zhang; G J Nabel; B Karpinski
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

6.  NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells.

Authors:  J A Molitor; W H Walker; S Doerre; D W Ballard; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene.

Authors:  D Ron; A R Brasier; K A Wright; J E Tate; J F Habener
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

8.  Regulation of the mouse alpha A-crystallin gene: isolation of a cDNA encoding a protein that binds to a cis sequence motif shared with the major histocompatibility complex class I gene and other genes.

Authors:  T Nakamura; D M Donovan; K Hamada; C M Sax; B Norman; J R Flanagan; K Ozato; H Westphal; J Piatigorsky
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  An RNA polymerase II transcription factor has an associated DNA-dependent ATPase (dATPase) activity strongly stimulated by the TATA region of promoters.

Authors:  R C Conaway; J W Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Infection with the intracellular protozoan parasite Theileria parva induces constitutively high levels of NF-kappa B in bovine T lymphocytes.

Authors:  V Ivanov; B Stein; I Baumann; D A Dobbelaere; P Herrlich; R O Williams
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.